Fibromyalgia position paper.
Journal
Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521
Informations de publication
Date de publication:
Historique:
received:
24
02
2021
accepted:
15
04
2021
pubmed:
19
5
2021
medline:
29
6
2021
entrez:
18
5
2021
Statut:
ppublish
Résumé
Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.
Identifiants
pubmed: 34001303
pii: 17133
doi: 10.55563/clinexprheumatol/i19pig
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM